EXAGEN INC. - Common Stock, par value $0.001 per share (XGN)

Q1 2020 13F Holders as of 31 Mar 2020

Type / Class
Equity / Common Stock, par value $0.001 per share
Shares outstanding
22,037,221
Total 13F shares
3,874,615
Share change
-210,084
Total reported value
$61,755,000
Price per share
$15.94
Number of holders
32
Value change
-$13,974,978
Number of buys
17
Number of sells
18

Institutional Holders of EXAGEN INC. - Common Stock, par value $0.001 per share (XGN) as of Q1 2020

As of 31 Mar 2020, EXAGEN INC. - Common Stock, par value $0.001 per share (XGN) was held by 32 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 3,874,615 shares. The largest 10 holders included RTW INVESTMENTS, LP, WASATCH ADVISORS INC, VICTORY CAPITAL MANAGEMENT INC, VANGUARD GROUP INC, NEXT CENTURY GROWTH INVESTORS LLC, COWEN AND COMPANY, LLC, BlackRock Inc., CALAMOS ADVISORS LLC, Russell Investments Group, Ltd., and PERKINS CAPITAL MANAGEMENT INC. This page lists 32 institutional shareholders reporting positions in this security for the Q1 2020 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.